These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 2364394)

  • 1. Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).
    Hertel LW; Boder GB; Kroin JS; Rinzel SM; Poore GA; Todd GC; Grindey GB
    Cancer Res; 1990 Jul; 50(14):4417-22. PubMed ID: 2364394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on wild type and variant mouse leukemia L1210 cells.
    Cory AH; Hertel LW; Kroin JS; Cory JG
    Oncol Res; 1993; 5(2):59-63. PubMed ID: 8364254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias.
    Waud WR; Gilbert KS; Grindey GB; Worzalla JF
    Cancer Chemother Pharmacol; 1996; 38(2):178-80. PubMed ID: 8616909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.
    Ruiz van Haperen VW; Veerman G; Eriksson S; Boven E; Stegmann AP; Hermsen M; Vermorken JB; Pinedo HM; Peters GJ
    Cancer Res; 1994 Aug; 54(15):4138-43. PubMed ID: 8033147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization produced in vivo by once- vs. twice-weekly 2'2'-difluoro-2'-deoxycytidine (gemcitabine).
    Fields MT; Eisbruch A; Normolle D; Orfali A; Davis MA; Pu AT; Lawrence TS
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):785-91. PubMed ID: 10837965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.
    Shewach DS; Hahn TM; Chang E; Hertel LW; Lawrence TS
    Cancer Res; 1994 Jun; 54(12):3218-23. PubMed ID: 8205542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer.
    Braakhuis BJ; van Dongen GA; Vermorken JB; Snow GB
    Cancer Res; 1991 Jan; 51(1):211-4. PubMed ID: 1988086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line.
    Kazuno H; Sakamoto K; Fujioka A; Fukushima M; Matsuda A; Sasaki T
    Cancer Sci; 2005 May; 96(5):295-302. PubMed ID: 15904471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of 2',2'-diflurodeoxycytidine (gemcitabine) with tumor necrosis factor alpha or its mutein VI in murine leukemias L1210 and P388.
    Marańda E; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(2):113-9. PubMed ID: 9613709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive action of gemcitabine (2',2'-difluorodeoxycytidine) and 2-chlorodeoxyadenosine on murine leukemias L1210 and P388.
    Marañda E; Szmigielska A; Robak T
    Cancer Invest; 1999; 17(2):95-101. PubMed ID: 10071592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor uptake and elimination of 2',2'-difluoro-2'-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response.
    Blackstock AW; Lightfoot H; Case LD; Tepper JE; Mukherji SK; Mitchell BS; Swarts SG; Hess SM
    Clin Cancer Res; 2001 Oct; 7(10):3263-8. PubMed ID: 11595723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 13. Activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human tumor colony forming units.
    Hanauske AR; Degen D; Marshall MH; Hilsenbeck SG; Grindey GB; Von Hoff DD
    Anticancer Drugs; 1992 Apr; 3(2):143-6. PubMed ID: 1525392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
    Lech-Maranda E; Korycka A; Robak T
    Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of p53 in gemcitabine mediated cytotoxicity and radiosensitivity in breast cancer cell lines.
    Salem SD; Abou-Tarboush FM; Saeed NM; Al-Qadasi WD; Farah MA; Al-Buhairi M; Al-Harbi N; Alhazza I; Alsbeih G
    Gene; 2012 May; 498(2):300-7. PubMed ID: 22353361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
    Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
    J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2',2'-difluoro-2'-deoxycytidine (Gemcitabine).
    Lawrence TS; Chang EY; Hahn TM; Shewach DS
    Clin Cancer Res; 1997 May; 3(5):777-82. PubMed ID: 9815749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
    Lawrence TS; Chang EY; Hahn TM; Hertel LW; Shewach DS
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):867-72. PubMed ID: 8598364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
    Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of DNA synthesis inhibition in the cytotoxicity of 2',2'-difluoro-2'-deoxycytidine.
    Ostruszka LJ; Shewach DS
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):325-32. PubMed ID: 12811514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.